Crossject SA funding
Crossject SA, a pharmaceuticals company based in Dijon, France, filed a Form D with the SEC on June 5, 2026 and reported a $10.3M offering.
Amount raised$0
Offering size$10.3M
Filed with the SECJune 5, 2026
First saleMay 27, 2026
IndustryPharmaceuticals
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationDijon, France
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far2
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 5
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology